Becton Dickinson on Monday said it plans to sell its Clontech business unit, putting on the sales block one of the most recognized brand assets in the molecular biology tools market.

The Franklin Lakes, NJ-based BD said it has retained Goldman Sachs to manage the deal and plans to take a $125 million pre-tax charge contingent upon completion of any sale of Clontech, a company acquired for $201 million in 1999. Clontech has 220 employees.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.